Cargando…
PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells
Glioblastoma is the most frequent and most aggressive brain tumour in adults. Temozolomide is an oral chemotherapy drug and one of the major components of chemotherapy regimens used as a treatment of some brain cancers. We examined the tolerance of stem cells isolated from glioma cell line U87 and U...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201353/ https://www.ncbi.nlm.nih.gov/pubmed/30133120 http://dx.doi.org/10.1111/jcmm.13793 |